News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AVANIR Pharmaceuticals (AVNR) Announces Date of Fiscal 2013 First Quarter Financial Results and Conference Call


1/30/2013 6:48:10 AM

ALISO VIEJO, Calif., Jan. 30, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended December 31, 2012 after market close on Thursday February 7, 2013. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1 (866) 783-2141
International callers: +1 (857) 350-1600
Passcode: 51423033

Webcast information: Visit http://www.avanir.com.

A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617) 801-6888 for international callers, and entering reservation code 87153907.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIRĀ® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

Ā©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES